The Keap1 gene mutation has been previously identified in 3–5% of non-small cell lung cancer (NSCLC) cases (8,14,15), however, the correlation between the mutation status and clinicopathological features was not well defined. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.